HRA009522
Title:
NeoPalAna
Release date:
2025-11-05
Description:
The NeoPalAna trial (NCT01723774) is a multi-cohort single arm phase 2 neoadjuvant study of the CDK4/6i palbociclib (PAL) plus anastrozole (ANA) in clinical stage II/III ER+/HER2- BC aimed to assess the antiproliferative effect of PAL in primary BC and to discover response biomarkers. Biomarkers were investigated with RNASeq, whole exome sequencing, and mass spectrometry data.
Data Accessibility:   
Controlled access Request Data
BioProject:
Study type:
Disease Study
Disease name:
breast cancer
Data Access Committee

For each controlled access study, there is a corresponding Data Access Committee(DAC) to determine the access permissions. Access to actual data files is not managed by NGDC.


DAC NO.:
DAC name:
Dr. Cynthia Ma
Contact person:
Ma Cynthia
Email:
cynthiaxma@wustl.edu
Description:
principal investigator of the NeoPalAna study
Individuals & samples
Submitter:   Ma Cynthia / cynthiaxma@wustl.edu
Organization:   Washington University (St. Louis)
Submission date:   2024-10-26
Requests:   1